CooperCompanies (COO) Reports Q1: Everything You Need To Know Ahead Of Earnings
CooperCompanies (COO) is set to report Q1 earnings Thursday after the bell. The company reported Q1 revenue of $1.02B, up 6.2% year over year, meeting analyst expectations; it also beat full-year EPS guidance. For Q1, analysts expect revenue growth of 5.1% y/y. The average analyst price target is $88.21 vs. $59.50 current.
How this was made
The 30-second read
Why it matters
Traders can use the consensus growth slowdown (6.3% to 5.1% YoY) plus the company’s recent revenue-miss pattern to frame downside risk and the likelihood of a volatility event around the after-hours print.
Market read
COO is heading into earnings with a large gap between analyst price target ($88.21) and the current share price ($59.50), while peers’ beats and sector strength could increase expectations.
What to watch
The piece doesn’t quantify margin, guidance, or segment drivers; those could dominate the reaction if they diverge from the revenue-growth narrative.
Background
The article is a pre-earnings checklist for CooperCompanies, referencing last quarter’s results, current consensus, and recent revenue-estimate history.
Ticker impact
CooperCompanies reports Q1 earnings this Thursday after the bell, with expectations for 5.1% YoY revenue growth and prior revenue misses noted.
Moderate two-sided move risk into the print; direction likely depends on revenue vs. expectations and any commentary on organic growth.
The article provides consensus growth expectations, highlights a recent pattern of revenue misses, and frames peers’ beats as potential read-across—enough to inform pre-earnings risk, but no new company-specific datapoint beyond the upcoming event.
Market effects
Peer results (Baxter, Boston Scientific) suggest diversified med-tech demand may be holding up, raising the bar for COO’s revenue performance.
Primarily US-listed med-tech sentiment; no specific regional demand shock cited.
Limited—article focuses on US earnings expectations and near-term read-across rather than global macro or regulatory changes.
Counterpoint
If COO’s organic revenue is in line while EPS beat was strong last quarter, the market may reward quality of earnings even without a revenue beat.
Key entities
- companyCooperCompanies
Subject of the article; scheduled to report Q1 earnings after the bell Thursday.
- peerBaxter
Reported Q1 revenue growth of 2.9% and beat expectations by 3.5%, trading up 1.8% after results.
- peerBoston Scientific
Reported Q1 revenues up 11.6%, topping estimates by 0.5%, and traded up 10.4% after results.
